Literature DB >> 17978811

Confounding: what it is and how to deal with it.

K J Jager1, C Zoccali, A Macleod, F W Dekker.   

Abstract

As confounding obscures the 'real' effect of an exposure on outcome, investigators performing etiological studies do their utmost best to prevent or control confounding. Unfortunately, in this process, errors are frequently made. This paper explains that to be a potential confounder, a variable needs to satisfy all three of the following criteria: (1) it must have an association with the disease, that is, it should be a risk factor for the disease; (2) it must be associated with the exposure, that is, it must be unequally distributed between exposure groups; and (3) it must not be an effect of the exposure; this also means that it may not be part of the causal pathway. In addition, a number of different techniques are described that may be applied to prevent or control for confounding: randomization, restriction, matching, and stratification. Finally, a number of examples outline commonly made errors, most of which result from 'overadjustment' for variables that do not satisfy the criteria for potential confounders. Such an example of an error frequently occurring in the literature is the incorrect adjustment for blood pressure while studying the relationship between body mass index and the development of end-stage renal disease. Such errors will introduce new bias instead of preventing it.

Entities:  

Mesh:

Year:  2007        PMID: 17978811     DOI: 10.1038/sj.ki.5002650

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  87 in total

1.  Competitive interaction between fibroblast growth factor 23 and asymmetric dimethylarginine in patients with CKD.

Authors:  Giovanni Tripepi; Barbara Kollerits; Daniela Leonardis; Mahamut Ilker Yilmaz; Maurizio Postorino; Danilo Fliser; Francesca Mallamaci; Florian Kronenberg; Carmine Zoccali
Journal:  J Am Soc Nephrol       Date:  2014-08-22       Impact factor: 10.121

Review 2.  Confounding: what is it and how do we deal with it?

Authors:  Luis Henrique P Braga; Forough Farrokhyar; Mohit Bhandari
Journal:  Can J Surg       Date:  2012-04       Impact factor: 2.089

3.  Quantifying predictive capability of electronic health records for the most harmful breast cancer.

Authors:  Yirong Wu; Jun Fan; Peggy Peissig; Richard Berg; Ahmad Pahlavan Tafti; Jie Yin; Ming Yuan; David Page; Jennifer Cox; Elizabeth S Burnside
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2018-03-07

4.  Adult height in patients with advanced CKD requiring renal replacement therapy during childhood.

Authors:  Jérôme Harambat; Marjolein Bonthuis; Karlijn J van Stralen; Gema Ariceta; Nina Battelino; Anna Bjerre; Timo Jahnukainen; Valérie Leroy; György Reusz; Ana R Sandes; Manish D Sinha; Jaap W Groothoff; Christian Combe; Kitty J Jager; Enrico Verrina; Franz Schaefer
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 8.237

5.  Small area deprivation and stigmatising attitudes towards mental illness: a multilevel analysis of Health Survey for England (2014) data.

Authors:  Elizabeth Ingram; Rebecca Jones; Peter Schofield; Claire Henderson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-05-04       Impact factor: 4.328

6.  Mediation analyses: applications in nutrition research and reading the literature.

Authors:  Chondra M Lockwood; Carol A DeFrancesco; Diane L Elliot; Shirley A A Beresford; Deborah J Toobert
Journal:  J Am Diet Assoc       Date:  2010-05

7.  Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD.

Authors:  Belinda Spoto; Francesco Mattace-Raso; Eric Sijbrands; Daniela Leonardis; Alessandra Testa; Anna Pisano; Patrizia Pizzini; Sebastiano Cutrupi; Rosa M Parlongo; Graziella D'Arrigo; Giovanni Tripepi; Francesca Mallamaci; Carmine Zoccali
Journal:  Clin J Am Soc Nephrol       Date:  2014-12-09       Impact factor: 8.237

8.  The possible role of early post-transplant inflammation in later anemia in kidney transplant recipients.

Authors:  Goran Imamović; Enver Zerem; Safet Omerović; Enes Osmanović; Emir Hodzić
Journal:  Bosn J Basic Med Sci       Date:  2009-11       Impact factor: 3.363

9.  CCR5 deletion protects against inflammation-associated mortality in dialysis patients.

Authors:  Friso L H Muntinghe; Marion Verduijn; Mike W Zuurman; Diana C Grootendorst; Juan Jesus Carrero; Abdul Rashid Qureshi; Karin Luttropp; Louise Nordfors; Bengt Lindholm; Vincent Brandenburg; Martin Schalling; Peter Stenvinkel; Elisabeth W Boeschoten; Raymond T Krediet; Gerjan Navis; Friedo W Dekker
Journal:  J Am Soc Nephrol       Date:  2009-04-23       Impact factor: 10.121

10.  Exploring the association between macroeconomic indicators and dialysis mortality.

Authors:  Anneke Kramer; Vianda S Stel; Fergus J Caskey; Benedicte Stengel; Robert F Elliott; Adrian Covic; Claudia Geue; Ana Cusumano; Alison M Macleod; Kitty J Jager
Journal:  Clin J Am Soc Nephrol       Date:  2012-07-26       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.